
News|Articles|February 8, 2024
mAb Characterization Process Innovations
Author(s)SCIEX
Earlier assessment of molecules provides valuable insights into the manufacturing developability of molecules, reducing the need for unnecessary experimentation. The Intabio ZT system has the potential to make in-depth characterization of biopharmaceutical product charge variants quicker and more efficient to meet demanding timelines during early-phase clinical development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks
3
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
4
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
5
